Introduction
============

Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation[@B1]. COPD has emerged as a serious public health concern in recent years, and is predicted to become the fourth leading cause of death worldwide by 2030[@B1][@B2].

The worldwide prevalence of COPD has been estimated to be 7.5%--10%[@B3]. In a nationwide COPD prevalence survey in Korea in conjunction with the second Korea National Health and Nutrition Examination Survey (KNHANES II) conducted 2001, 17.2% of Korean adults over the age of 45 years had COPD[@B4]. And, follow-up studies reported in 2011 showed the prevalence of COPD was 13.4% and 12.9%[@B5][@B6].

There were a few studies about the change of the prevalence of COPD, which showed the prevalence of COPD did not increase[@B7][@B8].

In this article, we briefly review the trends in the prevalence of COPD in Korea from 2007 to 2015 using the data from KNHANES[@B9].

Korea National Health and Nutrition Examination Survey (KNHANES)
================================================================

KNHANES is an ongoing surveillance system in the Republic of Korea that assesses the health and nutritional status of Koreans, monitors trends in health risk factors and the prevalence of major chronic diseases, and provides data for the development and evaluation of health policies and programs in Korea. KNHANES was initiated in 1998 by the union of "National Nutrition Survey" and the "National Health and Health Behavior Survey." Since then, surveys for the KNHANES I, II, III, IV, V, and VI have been executed. The first three KNHANES were conducted as a triannual survey. To reduce the limitation of seasonal variations, beginning with the fourth KNHANES in 2007, it was converted to an annual survey to provide timely national statistics. The survey for the KNHANES VII is under progress since 2016. The KNHANES uses rolling sampling survey method for the sample in each year to present the whole nation and to be similar by years. Twenty households were selected throughout 192 regions each year and 10,000 individuals aged 1 year and over were targeted for KNHANES[@B9].

In KNHANES, spirometry was performed by four technicians, each of whom underwent education sessions on pulmonary function test (PFT) and quality control[@B5][@B6]. Spirometry was performed using dry rolling seal spirometers (Model 2130; SensorMedics, Yorba Linda, CA, USA) and the American Thoracic Society/European Respiratory Society criteria for the standardization of PFT[@B10]. The prediction equation used in KNHANES was derived from the KNHANES II[@B11]. The results of spirometry in each enumeration districts were stored on web-hard to investigate whether the results satisfied acceptability and reproducibility criteria of spirometry for quality control and quality assurance. For analysis on results of spirometry, only results showing two or more acceptable curves and meeting reproducibility criteria were used[@B6].

Also, trained interviewers administered the questionnaire at the time of spirometry, to determine whether (1) the subject had a history of COPD, such as chronic bronchitis or emphysema; (2) had been diagnosed with COPD by a physician; and (3) had been treated for COPD[@B9].

The participants aged over 40 years recording less than 0.7 of forced expiratory volume in 1 second (FEV~1~)/forced vital capacity (FVC) were defined to have COPD[@B5][@B6]. To explore the trends of COPD prevalence from 2007 to 2015, KNHANES used age-standardized prevalence which was calculated using the age- and sex-specific structures of estimated population based on the 2005 Korea Census[@B9].

Prevalence and Awareness of COPD
================================

1. Prevalence of COPD in 2015
-----------------------------

In 2015, the prevalence of COPD was 13.4% (male, 21.6%; female, 5.8%) ([Table 1](#T1){ref-type="table"}). This figure was similar to those of previous studies[@B5][@B6]. The prevalence of the elderly aged over 65 years recorded 28.1% (male, 45.5%; female, 13.7%). And the prevalence became higher at older age by recording 4.1%, 9.7%, 21.2%, and 30.6% in the participants in their 40s, 50s, 60s, and 70s, respectively ([Figure 1](#F1){ref-type="fig"}). In addition, the prevalence of COPD was higher in low income subjects than that of high income subjects ([Table 1](#T1){ref-type="table"}).

2. Trends in prevalence of COPD
-------------------------------

After conversion of annual survey during KNHNES IV, the prevalence of COPD seemed to be decreasing. However, the prevalence of COPD did not change much after 2010, which ranged from 13.1% to 14.6% during the period from 2010 to 2015 ([Table 2](#T2){ref-type="table"}).

KNHANES used the age- and sex-specific structures estimated population based on the 2005 Korea Census to explore the trends in prevalence of COPD. The age-standardized prevalence of COPD showed similar pattern ([Table 2](#T2){ref-type="table"}, [Figure 2](#F2){ref-type="fig"}). This non-increase tendency of prevalence was comparable to other studies[@B7][@B8].

3. Awareness of COPD
--------------------

It is well known that the public awareness of COPD is limited[@B12][@B13][@B14] and a significant number of COPD patients have undiagnosed[@B15][@B16]. Among the subjects found to have COPD by spirometry, only 2.8% had been diagnosed as COPD by physicians during the period from 2011 and 2015. The treatment rate was 1.6% ([Table 3](#T3){ref-type="table"}). This figure did not improve compared to previous studies[@B5][@B6].

4. Limitations of KNHANES
-------------------------

KNHANES had some limitations. First, it did not exclude other diseases associated with airflow obstruction such as bronchiectasis and tuberculous destroyed lung because it did not utilize chest radiography. Second, the existence of airflow obstruction was evaluated with a fixed ratio using FEV~1~/FVC \<0.7, so that the prevalence of the elderly could be overestimated. Moreover, as the golden standard of detecting COPD was based on postbronchodilator spirometry, KNHANES used only prebronchodilator test.

Conclusion
==========

The prevalence of COPD among Korean adults aged over 40 years was 13.4% in 2015. The prevalence of COPD did not change significantly during the period from 2010 to 2015. And most COPD patients still had not been diagnosed by physicians and consequently had not been treated appropriately.
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###### Prevalence of chronic obstructive pulmonary disease in 2015, stratified by age and income

![](trd-80-226-i001)

                  Total (%)   Male (%)   Female (%)
  --------------- ----------- ---------- ------------
  Age, yr                                
   ≥40            13.4        21.6       5.8
   ≥65            28.1        45.5       13.7
  Age group, yr                          
   40--49         4.1         7.3        0.8
   50--59         9.7         16.8       2.4
   60--69         21.2        34.1       11.4
   ≥70            30.6        51.7       13.6
  Income^\*^                             
   Low            14.6        23.2       5.9
   Low--middle    15.0        24.5       6.8
   Middle--high   11.8        19.6       4.4
   High           12.2        19.2       6.0

^\*^Income was categorized by ranking according to gender and age group at 5-year intervals. Each subject\'s income was calculated by dividing the total household income by the square root of the number of members in the household.

###### Prevalence of COPD during the period from 2007 to 2015 (%)

![](trd-80-226-i002)

                  2007   2008   2009   2010   2011   2012   2013   2014   2015
  --------------- ------ ------ ------ ------ ------ ------ ------ ------ ------
  Age, yr                                                                 
   ≥40            15.6   13.4   11.0   13.1   13.2   14.6   13.5   14.2   13.4
   ≥65            34.0   31.1   23.6   31.9   27.8   30.2   31.5   31.1   28.1
   ≥40^\*^        15.3   13.1   10.5   12.3   12.5   13.7   12.8   13.4   12.3
  Age group, yr                                                           
   40--49         5.4    4.8    3.2    2.8    4.0    4.3    3.5    5.3    4.1
   50--59         14.3   9.0    9.1    9.6    10.7   11.4   9.3    9.6    9.7
   60--69         21.5   21.4   17.7   20.3   21.7   24.9   22.1   20.6   21.2
   ≥70            38.8   34.8   26.2   35.8   29.3   31.6   35.2   35.9   30.6
  Income                                                                  
   Low            17.9   14.6   12.6   14.5   13.3   12.9   15.0   15.5   14.6
   Low--middle    18.3   13.2   10.3   14.4   13.9   17.1   11.8   12.6   15.0
   Middle--high   14.9   11.8   10.2   11.0   12.9   15.6   15.5   15.0   11.8
   High           10.2   10.7   10.5   12.5   11.9   13.3   11.3   13.5   12.2

^\*^Age-standardized prevalence (see "Materials and Methods").

COPD: chronic obstructive pulmonary disease.

###### Awareness of chronic obstructive pulmonary disease (%)
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                               Total   Male   Female
  ---------------------------- ------- ------ --------
  Diagnosed by the physician                  
   Age, yr                                    
    ≥40                        2.8     2.9    2.7
    ≥65                        3.3     3.9    1.9
   Age group, yr                              
    40--49                     1.6     1.9    0.0
    50--59                     1.6     1.5    2.2
    60--69                     3.2     3.0    3.9
    ≥70                        3.6     4.2    2.3
  Treated by the physician                    
   Age, yr                                    
    ≥40                        1.6     1.6    1.9
    ≥65                        2.1     2.3    1.6
   Age group, yr                              
    40--49                     0.0     0.0    0.0
    50--59                     1.2     1.0    2.2
    60--69                     1.5     1.2    2.1
    ≥70                        2.6     2.9    1.9
